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Introduction 
Following the UK’s vote to leave the European Union in the referendum of 23rd June 2016, we 
surveyed 100 health economists regarding their opinions on ‘Brexit’. Researchers have started to 
consider the challenges of Brexit (Oxford Review of Economic Policy, 2017). However the impact on 
health and health services is often not directly considered. The NHS has always been a political 
‘football’ and the EU referendum campaign was no exception. The “£350m-a-week” for the NHS 
claim, made during campaigning, was one of the most eye-catching elements of the Vote Leave 
message. However, as predicted by many commentators, this claim has been watered down 
following the vote to leave. 
With Article 50 triggered on 29th March, now is a valuable time to report on those views and the 
challenges that Brexit may pose. Academics and policy leaders (dare we call them “experts”?) are a 
rich source for considering where the benefits and challenges for the NHS lie and how, potentially, 
we can optimise the benefits and ameliorate the impact of the challenges – especially with no 
historical precedent to call on (as ibid). Even though all of our respondents (59% response rate) were 
in favour of remaining in the EU, they identified positives and negatives, with a key focus on the 
labour force and the single market. 
The survey 
We used Survey Monkey to elicit the views of 100 senior health economists (including economists 
with an interest in health) between 12th Oct and 22nd Oct 2016. The selection, which focussed on 
researchers from universities and policy think-tanks,  was guided by the IDEAS-Research Papers in 
Economics Top Economists in the Field of Health Economics 
(https://ideas.repec.org/top/top.hea.html).  
We surveyed economists from outside (the US, Canada and Australia) and inside the EU  (including 
England and Wales, Scotland and Northern Ireland) and received 59 responses. 
Open-ended questions were used to generate ideas and gather a range of views. There was no 
attempt to represent a population, adjust for response selection, or estimate the prevalence or 
strength of views.  We report a basic thematic analysis which we integrate with discussion, adding 
context to the issues raised by respondents.  The questions posed were: 
 Thinking of health and health services in the UK, describe up to three POSITIVE outcomes 
that may arise from Brexit. 
 Thinking of health and health services in the UK, describe up to three NEGATIVE outcomes 
that may arise from Brexit. 
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 Thinking of health and health services in the UK, if you were advising the UK Government on 
Brexit negotiations what would be the ONE key issue in the negotiations that you would 
insist upon, and why? 
 In what ways will Brexit affect research in health and health care funding and delivery? 
Emerging themes 
Responses could be categorised into two main themes: issues relating to the economy (and the 
single market) and issues relating to labour markets. It is unsurprising, given the whole nature of the 
Brexit debate, that growth/recession and immigration dominate the concerns. 
The economy, health and health services 
The role of the economy for health is vital, with health spending being closely linked to GDP. Any 
Brexit consequences on the economy will affect spending on the NHS. ‘…if Brexit turned out to be 
good for the economy, then more growth [would lead to] more money for the NHS.’ However, if a 
recession occurs, or if growth is lower than expected (or lower than it would have been without 
Brexit),  then “NHS expenditure will suffer”. Austerity has already seen NHS spending increases at 
their lowest level for some time, with funding barely increasing in real terms between 2010 and 
2015 (King’s Fund, 2015).  
What must also be considered, but was not raised by any respondent, is that the EU is not immune 
to these changes. Health spending in the EU will also respond to the economic changes and will have 
health consequences across Europe. Although the link between recessions and health is debated 
(Ruhm, 2005, 2015), a considerable literature positively links income and health (Case et al., 2002). It 
is possible that Brexit will lead to a slowing in economic growth across the globe. With the UK 
Government saying that it will not look to stay in the single market, key trade deals will need to be 
negotiated to ensure that the economies of the UK and Europe do not suffer. 
In terms of exports, our respondents viewed the depreciation of the pound as a positive. With the 
UK as one of the largest exporters of pharmaceutical products in the world, any benefits in the 
export market will add value to the economy. The outlook for pharmaceuticals post-Brexit may be 
strong given the recent announcements by Novo Nordisk and GlaxoSmithKline of large investments 
in the UK, suggesting that fears regarding the Brexit vote may not be as large as some experts fear. 
Respondents did note, however, that the loss of the European Medicines Agency will mean that new 
regulatory and evaluations frameworks will need to be put in place, with, as one respondent noted, 
“huge implications for clinical trials”. 
For utilisation and health, several respondents highlighted the possibility of a “reduction in pressure 
on NHS services due to reduced demand” and that health may improve due to “greater security”. 
However, many raised the possibility of “long waiting times” and, more gloomily “…evidence shows 
that natural disasters affect mental health; this political disaster will be no different”. 
The direction of the political debate also matters. If the Government does, as a respondent hoped, 
“take the plight of the deprived regions more seriously” and use the post-Brexit political landscape 
to rebalance the economy, focus on those ‘just about managing’ (JAMs) and tackle social 
inequalities, then population health may improve. If social inequalities narrow, and the relative 
income hypothesis of Wilkinson (1996) holds true, then the UK could benefit. 
If however, as many of our respondents feared, social inequality widens, “increase[ing] health 
inequalities through economic troubles”, and more divisions arise due to a “rise in nationalism and 
  
isolationism”, then the same arguments could be used to suggest widening health inequalities and 
falling population level health.  
Sovereignty - “the ability to maintain an NHS (if we want)” - and trade deals were other key issues 
raised by our respondents. The Trans-Atlantic Trade and Investment Partnership (TTIP), although 
now seemingly dead in the water, potentially threatened the NHS and EU publicly funded health 
services. Being outside of the EU may provide greater scope for protecting the NHS and retaining a 
health service that reflects the values of the population. However, it was interesting to note that 
none of the respondents suggested that bi-lateral trade deals may include pressure to open the NHS 
to international private interests. It is also worth noting that the Canadian agreement with the EU, 
which the UK is still signed up to, also enables private firms to access UK markets as long as they 
have a base in Canada. 
Health (and academic) human resources 
The labour market was a major concern among respondents. The NHS – and the social care sector - 
are heavily dependent on migrant labour. With the UK Government committed to restricting the 
free movement of labour, there will be staffing challenges in an over-worked and low-morale sector. 
The promise of a points-based system may allow for the targeting of high skilled workers, such as 
doctors and the more highly trained health professionals. However it may be much harder to attract, 
and allow entry to, sufficient numbers of middle and low-skilled workers (Migration Observatory, 
2017). Such problems will be exacerbated if immigration targets lead to caps on overseas 
recruitment - for instance, nurses are already considered a shortage profession but have a cap on 
the number of non-EU recruits. The NHS could previously circumvent this cap by recruiting nurses 
from Europe; a route that may no longer be available post-Brexit. 
In response to the labour market challenges, some respondents noted the possibility of a greater 
focus on training health professionals domestically. In the wake of the Brexit vote, the Government 
immediately announced a rise in the number of training places for doctors, and changes have been 
made to the funding system for training nurses, with the (currently forlorn) hope that it will increase 
the numbers in training. Increasing the skills and education of the native workforce was considered 
to be positive by many health economists and could benefit health, productivity and the economy 
more widely. Similarly, it should be noted that immigration changes may provide some benefits for 
the countries that provide many NHS staff. If fewer skilled people - and often migrants are over 
skilled for the level of work they take on in their destination countries - leave their native countries, 
then they may boost the levels of the skilled workforce in countries that are often still developing. 
Respondents were fearful of the impact of Brexit on health research. This is clearly going to be a 
challenging area for the Government post-Brexit. Most respondents acknowledged the impact on 
research funding that will result from the loss of EU funding streams. But more important concerns 
were raised about Brexit limiting the opportunities for international research collaborations and 
consortia, - the sharing of ideas, research competition and the ability to undertake comparative 
analysis - with medical research, health service research and socio-economic research all suffering, 
in both the UK and the EU. Although such fears may be partly compensated by the announcement of 
Global Challenge Initiatives, funding that aims to build capacity through partnerships with low- and 
middle-income countries, rather than collaboration with partners who are already internationally 
recognised. 
The challenges for the UK research sector are particularly stark. With the UK reliant on so many EU 
researchers, whose positions in the UK are not guaranteed, there is a risk of a ‘brain drain’. With 
  
labour market restrictions that may arise from a new immigration policy, recruitment and retention 
of skilled researchers may become difficult as the “UK won’t be attractive to good Europeans”. A 
further problem may be that UK academics, who were largely against Brexit, may also choose to 
leave the UK - although Trump's America may currently also seem unattractive!  
Conclusion 
Brexit poses many challenges. Regarding positives, many respondents felt there were “none”. For 
the negotiations, our respondents placed great importance on the single market and the free 
movement of labour (more than one wrote “don’t do it”), although we now know that the 
Government will not commit to these. However, potential positives, that need to be built upon, 
were identified. 
Ultimately, Brexit presents a challenge for academia itself. None of our respondents voted (or, if 
they were not eligible, stated that they would have voted) to leave. Many of the responses were 
angry at the decision to vote leave. While it is vital that the academic health economics profession 
continues to make the arguments, whether they are pro-leave or pro-remain, it is important that we 
do not lose sight of the fact that Brexit is happening and we, as academics, need to consider Brexit 
objectively, by researching it, and asking questions of it, as we would any other change. As Hamlet 
might have put it, “there is nothing either good or bad, but thinking makes it so”. Intended and 
unintended consequences, positive and negative, will arise; the academic profession will only have 
something meaningful to say if it can research these fairly and without bias. Furthermore, the 
profession needs to find ways to make Brexit, whatever it finally looks like, work - contributing to the 
policy debate and the research literature with the aim of benefitting society. In this respect, we 
already have strengths in place within health economics to guide research into the implications for 
health inequalities, health human resources and the nexus of trade and health policy. 
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